Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Effect of Dimethyl Fumarate vs Interferon β-1a in Patients With Pediatric-Onset Multiple Sclerosis: The CONNECT Randomized Clinical TrialJAMA Netw Open 2022 Sep 28;5(9)e2230439, P Vermersch, M Scaramozza, S Levin, R Alroughani, K Deiva, C Pozzilli, J Lyons, O Mokliatchouk, J Pultz, F N'Dure, S Liu, R Badwan, F Branco, V Hood-Humphrey, N Franchimont, J Hanna, AH Maghzi
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.